← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2013Last known activity
Jun 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT05400031Study chairN/AJun 1, 2022
- NCT05400031CollaboratorN/AJun 1, 2022
- NCT05150847Lead sponsorN/ADec 25, 2021
- NCT05150847Reponsible party - principal investigatorN/ADec 25, 2021
- NCT05150847Study chairN/ADec 25, 2021
- NCT04411433CollaboratorPhase 3May 8, 2020
- NCT03037606Overall official - principal investigatorPhase 4Jul 1, 2017
- NCT01917396Overall official - principal investigatorN/AAug 1, 2013
Details
- Last known activity
- Jun 1, 2022